71 results
Page 2 of 4
8-K
EX-99.1
zf6v8a6
4 Apr 22
Petros Pharmaceuticals Reports Year End 2021 Financial Results and Corporate Highlights
4:15pm
8-K
EX-10.3
1al6y2fiko07c32
21 Jan 22
Entry into a Material Definitive Agreement
4:30pm
424B3
bxrhiu26 pdjv7l8z0
14 Jan 22
Prospectus supplement
5:18pm
D
kmg1tn2
3 Jan 22
$8.32M in equity / options / securities to be acquired, sold $2.2M, 12 investors
5:16pm
8-K
EX-10.1
ipqpb 5qk6zht5
27 Dec 21
Petros Pharmaceuticals Announces $7.5 Million Offering
5:02pm
424B5
nj8s63fzhhj 0uno5
23 Dec 21
Prospectus supplement for primary offering
5:01pm
D
z4ee4y0z6wus dh03
3 Dec 21
$12.82M in equity / options / securities to be acquired, sold $3.54M, 12 investors
4:16pm
8-K
EX-10.1
05ur rmh5
1 Dec 21
Petros Pharmaceuticals Announces $10 Million Offering
5:12pm
424B5
emjm0r
1 Dec 21
Prospectus supplement for primary offering
5:10pm
DEF 14A
0anzq7ifug
22 Nov 21
Definitive proxy
4:37pm
8-K
EX-99.1
53rbsb8lavcb
16 Nov 21
Petros Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update
12:00am
D
3m6 uhaa2yaz
26 Oct 21
$5.92M in options / securities to be acquired, 10 investors
1:39pm
8-K
EX-10.1
cm8xbr
15 Oct 21
Petros Pharmaceuticals Announces $5.7 Million Registered Direct Offering
5:03pm
424B5
p7mlbykrvkqnhp zo9pn
15 Oct 21
Prospectus supplement for primary offering
5:01pm